ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,213.49
0.51%
Dow Jones
38,675.68
1.18%
Gold vs US Dollar
2,302.57
0.00%
Brent Oil
82.765
0.00%
Bitcoin
63,229.54
0.54%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Aclarion Inc (ACON)

  7. Aclarion Inc (ACON) News

Aclarion (ACON)

Aclarion Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ACON
DateTimeSourceHeadlineSymbolCompany
25/04/202414:14GlobeNewswire Inc.Aclarion’s Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back PainNASDAQ:ACONAclarion Inc
06/03/202421:09Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ACONAclarion Inc
04/03/202413:00GlobeNewswire Inc.Aclarion Announces Publication of Compelling Peer-Reviewed Data in International Journal of Spine Surgery Supporting Nociscan as a Gold Standard for Noninvasive Identification of Painful Lumbar DiscsNASDAQ:ACONAclarion Inc
27/02/202420:22GlobeNewswire Inc.Aclarion Announces Closing of $3.0 Million Public OfferingNASDAQ:ACONAclarion Inc
27/02/202419:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONAclarion Inc
27/02/202415:46Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ACONAclarion Inc
27/02/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ACONAclarion Inc
26/02/202414:15GlobeNewswire Inc.Aclarion Announces Pricing of $3.0 Million Public OfferingNASDAQ:ACONAclarion Inc
23/02/202416:46Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ACONAclarion Inc
21/02/202422:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONAclarion Inc
21/02/202420:02Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ACONAclarion Inc
06/02/202422:32Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ACONAclarion Inc
05/02/202413:00GlobeNewswire Inc.Aclarion Announces Successful Financings; Plans to Launch CLARITY Trial and Provides Update on Next Steps of Alphatec Strategic PartnershipNASDAQ:ACONAclarion Inc
02/02/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ACONAclarion Inc
01/02/202422:16Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ACONAclarion Inc
31/01/202422:26Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ACONAclarion Inc
29/01/202411:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONAclarion Inc
23/01/202414:53Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONAclarion Inc
22/01/202421:48Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ACONAclarion Inc
22/01/202413:00GlobeNewswire Inc.Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MDNASDAQ:ACONAclarion Inc
17/01/202413:00GlobeNewswire Inc.Aclarion Announces Updated Product Release That Expands MRI Scanner Access for Nociscan SolutionNASDAQ:ACONAclarion Inc
12/01/202421:15Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ACONAclarion Inc
08/01/202413:00GlobeNewswire Inc.Aclarion and ATEC Execute Strategic Partnership Agreement to Advance Commercialization of NociscanNASDAQ:ACONAclarion Inc
04/01/202413:01Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ACONAclarion Inc
04/01/202413:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONAclarion Inc
02/01/202417:00GlobeNewswire Inc.Aclarion Announces Reverse Stock SplitNASDAQ:ACONAclarion Inc
29/12/202311:30Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ACONAclarion Inc
19/12/202321:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONAclarion Inc
11/12/202321:55Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ACONAclarion Inc
27/11/202313:00GlobeNewswire Inc.Aclarion Announces Key Commercial Milestone With Completion of 1,000 Nociscan ExamsNASDAQ:ACONAclarion Inc
 Showing the most relevant articles for your search:NASDAQ:ACON

Your Recent History

LSE
MIN
Minoan
LSE
TERN
Tern
LSE
FME
Future Metals Nl
LSE
AAL
Anglo American
LSE
VTY
Vistry
LSE
RGL
Regional Reit
LSE
MNL
Manchester & London Inve...
LSE
SCLP
Scancell
LSE
MILA
Mila Resources
LSE
TXP
Touchstone Exploration
LSE
GKP
Gulf Keystone Petroleum
LSE
LLOY
Lloyds Banking
LSE
VOD
Vodafone
LSE
HSBA
Hsbc
LSE
ALBA
Alba Mineral Resources
LSE
EME
Empyrean Energy
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved